Telomeres in disease

F1000 Medicine Reports

Volumn 4, Issue 1, 2012, Pages

  Calado, Rodrigo ^a   Young, Neal ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSKERIN; PROTEIN P53; TELOMERASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANEUPLOIDY; APLASTIC ANEMIA; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CELL AGING; CELL DEATH; CELL DIVISION; CELL ELONGATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME; DNA DAMAGE; DYSKERATOSIS CONGENITA; EMBRYO DEVELOPMENT; GENE MUTATION; GENETIC ASSOCIATION; GLUCOSE METABOLISM; HEART DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; LIFESTYLE MODIFICATION; LIVER CIRRHOSIS; LUNG FIBROSIS; MITOCHONDRION; MYELODYSPLASTIC SYNDROME; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; SENESCENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL GENETICS; TELOMERE; TELOMERE SHORTENING; TONGUE CANCER; ULCERATIVE COLITIS;

EID: 84859568120     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M4-8     Document Type: Article

References (32)

1. Olovnikov AM: Printsip marginotomii v matrichnom sinteze polinukleotidov. Dokl Akad Nauk SSSR 1971, 201:1496-9. F1000 Factor 10 Evaluated by Neal Young 15 Mar 2012
2. Watson JD: Origin of concatemeric T7 DNA. Nature New Biol 1972, 239:197-201. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
3. Blackburn EH: Switching and signaling at the telomere. Cell 2001, 106:661-73.
4. Blackburn EH, Greider CW, Szostak JW: Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006, 12:1133-8. (Pubitemid 44527346)
5. de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100-10.
6. Aubert G, Lansdorp PM: Telomeres and aging. Physiol Rev 2008, 88:557-79. (Pubitemid 351522746)
7. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-13. F1000 Factor 8 Evaluated by Neal Young 15 Mar 2012
8. Reddel RR: Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 2003, 194:155-62. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
9. Calado RT, Young NS: Telomere diseases. N Engl J Med 2009, 361:2353-65.
10. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I: X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998, 19:32-8. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
11. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I: The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001, 413:432-5. F1000 Factor 8 Evaluated by Titia De Lange 23 Oct 2001
12. Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, Peters JA, Giri N, Lansdorp PM: Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007, 110:1439-47. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
13. Scheinberg P, Cooper JN, Sloand EM, Wu CO, Calado RT, Young NS: Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA 2010, 304:1358-64. F1000 Factor 10 Evaluated by Eva Guinan 27 Sept 2011, Sharon Savage and Shahinaz Gadalla 9 Dec 2010, Albert N Békássy 9 Nov 2010
14. Calado RT, Regal JA, Hills M, Yewdell WT, Dalmazzo LF, Zago MA, Lansdorp PM, Hogge D, Chanock SJ, Estey EH, Falcão RP, Young NS: Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U.S.A 2009, 106:1187-92. F1000 Factor 8 Evaluated by Laura Haneline 28 Apr 2009
15. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen W, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch PS: Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-4. F1000 Factor 8 Evaluated by Neal Young 15 Mar 2012
16. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, Gallaher JL, Reid BJ, Rabinovitch PS: Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007, 16:2649-55. F1000 Factor 8 Evaluated by Neal Young 15 Mar 2012
17. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KKH, Blöndal T, Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Ragnarsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K, Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Matthiasdottir S, Sveinsdottir SG, et al.: Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009, 41:221-7. F1000 Factor 8 Evaluated by Neal Young 15 Mar 2012
18. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A, Kronenberg F, Kiechl S: Telomere length and risk of incident cancer and cancer mortality. JAMA 2010, 304:69-75. F1000 Factor 7 Evaluated by Lodovico Balducci 25 Aug 2010, Sharon Savage 21 Jul 2010
19. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA: Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-5. F1000 Factor 8 Evaluated by Neal Young 15 Mar 2012
20. Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Hardikar S, Aviv A: Leukocyte telomerelength and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 2011, 66:421-9. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
21. Kimura M, Hjelmborg JVB, Gardner JP, Bathum L, Brimacombe M, Lu X, Christiansen L, Vaupel JW, Aviv A, Christensen K: Telomere length and mortality: a study of leukocytes in elderly Danish twins. Am J Epidemiol 2008, 167:799-806. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
22. Bakaysa SL, Mucci LA, Slagboom PE, Boomsma DI, McClearn GE, Johansson B, Pedersen NL: Telomere length predicts survival independent of genetic influences. Aging Cell 2007, 6:769-74. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
23. Ehrlenbach S, Willeit P, Kiechl S, Willeit J, Reindl M, Schanda K, Kronenberg F, Brandstätter A: Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. Int J Epidemiol 2009, 38:1725-34. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
24. Njajou OT, Hsueh W, Blackburn EH, Newman AB, Wu S, Li R, Simonsick EM, Harris TM, Cummings SR, Cawthon RM: Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population- based cohort study. J Gerontol A Biol Sci Med Sci 2009, 64:860-4. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
25. Bischoff C, Petersen HC, Graakjaer J, Andersen-Ranberg K, Vaupel JW, Bohr VA, Kølvraa S, Christensen K: No association between telomere length and survival among the elderly and oldest old. Epidemiology 2006, 17:190-4.
26. Houben JMJ, Giltay EJ, Rius-Ottenheim N, Hageman GJ, Kromhout D: Telomere length and mortality in elderly men: the Zutphen Elderly Study. J Gerontol A Biol Sci Med Sci 2011, 66:38-44. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
27. Strandberg TE, Saijonmaa O, Tilvis RS, Pitkälä KH, Strandberg AY, Miettinen TA, Fyhrquist F: Association of telomere length in older men with mortality and midlife body mass index and smoking. J Gerontol A Biol Sci Med Sci 2011, 66:815-20. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
28. Epel ES, Merkin SS, Cawthon R, Blackburn EH, Adler NE, Pletcher MJ, Seeman TE: The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging 2009, 1:81-8. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
29. Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA: Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011, 470:359-65. F1000 Factor 12 Evaluated by Lucio Comai 21 Mar 2011, Kevin Conley 16 March 2011
30. Shiels PG, Kind AJ, Campbell KH, Waddington D, Wilmut I, Colman A, Schnieke AE: Analysis of telomere lengths in cloned sheep. Nature 1999, 399:316-7. F1000 Factor 6 Evaluated by Neal Young 15 Mar 2012
31. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA: Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-54. F1000 Factor 8 Evaluated by Neal Young 15 Mar 2012
32. Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, Young NS: Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009, 114:2236-43.